Results 1 - 20 of 21 for All Library Resources
Sorted by:
Sorted by:
RelevanceOr hit Enter to replace sort method
- Relevance
- Date-newest
- Date-oldest
- Popularity
- Author
- Title
Refined by:
Journal Title:
The Lancet Infectious Diseases
| Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
|---|---|---|---|
| 1 |
Material Type: Article
|
|
SARS-CoV-2 infection and transmission in educational settings: a prospective, cross-sectional analysis of infection clusters and outbreaks in EnglandThe Lancet Infectious Diseases, 2021-03, Vol.21 (3), p.344-353 [Peer Reviewed Journal]2021 ;Crown Copyright © 2021 Published by Elsevier Ltd. All rights reserved. ;2020. Not withstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://www.elsevier.com/legal/elsevier-website-terms-and-conditions ;Copyright Elsevier Limited Mar 2021 ;Crown Copyright © 2020 Published by Elsevier Ltd. All rights reserved. 2021 ;ISSN: 1473-3099 ;EISSN: 1474-4457 ;DOI: 10.1016/S1473-3099(20)30882-3 ;PMID: 33306981Digital Resources/Online E-Resources |
| 2 |
Material Type: Article
|
|
Rapid increase in non-vaccine serotypes causing invasive pneumococcal disease in England and Wales, 2000–17: a prospective national observational cohort studyThe Lancet infectious diseases, 2018-04, Vol.18 (4), p.441-451 [Peer Reviewed Journal]2018 Elsevier Ltd ;Copyright © 2018 Elsevier Ltd. All rights reserved. ;Copyright Elsevier Limited Apr 1, 2018 ;ISSN: 1473-3099 ;EISSN: 1474-4457 ;DOI: 10.1016/S1473-3099(18)30052-5 ;PMID: 29395999Full text available |
| 3 |
Material Type: Article
|
|
Protection against symptomatic infection with delta (B.1.617.2) and omicron (B.1.1.529) BA.1 and BA.2 SARS-CoV-2 variants after previous infection and vaccination in adolescents in England, August, 2021–March, 2022: a national, observational, test-negative, case-control studyThe Lancet infectious diseases, 2023-04, Vol.23 (4), p.435-444 [Peer Reviewed Journal]2023 ;Crown Copyright © 2023 Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license. ;Copyright Elsevier Limited Apr 2023 ;Crown Copyright © 2022 Published by Elsevier Ltd. 2023 ;ISSN: 1473-3099 ;EISSN: 1474-4457 ;DOI: 10.1016/S1473-3099(22)00729-0 ;PMID: 36436536Full text available |
| 4 |
Material Type: Article
|
|
Effectiveness of BNT162b2 against COVID-19 in adolescentsThe Lancet infectious diseases, 2022-05, Vol.22 (5), p.581-583 [Peer Reviewed Journal]2022 Elsevier Ltd ;2022. Elsevier Ltd ;2022 Published by Elsevier Ltd. 2022 Elsevier Ltd ;ISSN: 1473-3099 ;EISSN: 1474-4457 ;DOI: 10.1016/S1473-3099(22)00177-3 ;PMID: 35325619Full text available |
| 5 |
Material Type: Article
|
|
Summary of evidence to reduce the two-dose infant priming schedule to a single dose of the 13-valent pneumococcal conjugate vaccine in the national immunisation programme in the UKThe Lancet infectious diseases, 2021-04, Vol.21 (4), p.e93-e102 [Peer Reviewed Journal]2021 Elsevier Ltd ;Copyright © 2021 Elsevier Ltd. All rights reserved. ;2021. Elsevier Ltd ;ISSN: 1473-3099 ;EISSN: 1474-4457 ;DOI: 10.1016/S1473-3099(20)30492-8 ;PMID: 33129426Full text available |
| 6 |
Material Type: Article
|
|
Trends in bacterial, mycobacterial, and fungal meningitis in England and Wales 2004–11: an observational studyThe Lancet infectious diseases, 2014-04, Vol.14 (4), p.301-307 [Peer Reviewed Journal]Elsevier Ltd ;2014 Elsevier Ltd ;2015 INIST-CNRS ;Copyright © 2014 Elsevier Ltd. All rights reserved. ;Copyright Elsevier Limited Apr 2014 ;ISSN: 1473-3099 ;EISSN: 1474-4457 ;DOI: 10.1016/S1473-3099(13)70332-3 ;PMID: 24508198 ;CODEN: LANCAOFull text available |
| 7 |
Material Type: Article
|
|
Strengthening the Reporting of Molecular Epidemiology for Infectious Diseases (STROME-ID): an extension of the STROBE statementThe Lancet infectious diseases, 2014-04, Vol.14 (4), p.341-352 [Peer Reviewed Journal]Elsevier Ltd ;2014 Elsevier Ltd ;2015 INIST-CNRS ;Copyright © 2014 Elsevier Ltd. All rights reserved. ;Copyright Elsevier Limited Apr 2014 ;ISSN: 1473-3099 ;EISSN: 1474-4457 ;DOI: 10.1016/S1473-3099(13)70324-4 ;PMID: 24631223 ;CODEN: LANCAOFull text available |
| 8 |
Material Type: Article
|
|
Meningococcal serogroup B strain coverage of the multicomponent 4CMenB vaccine with corresponding regional distribution and clinical characteristics in England, Wales, and Northern Ireland, 2007–08 and 2014–15: a qualitative and quantitative assessmentThe Lancet infectious diseases, 2017-07, Vol.17 (7), p.754-762 [Peer Reviewed Journal]Elsevier Ltd ;2017 Elsevier Ltd ;Copyright © 2017 Elsevier Ltd. All rights reserved. ;Copyright Elsevier Limited Jul 1, 2017 ;2017. Elsevier Ltd ;ISSN: 1473-3099 ;EISSN: 1474-4457 ;DOI: 10.1016/S1473-3099(17)30170-6 ;PMID: 28366725Full text available |
| 9 |
Material Type: Article
|
|
Early evaluation of the safety, reactogenicity, and immune response after a single dose of modified vaccinia Ankara–Bavaria Nordic vaccine against mpox in children: a national outbreak responseThe Lancet infectious diseases, 2023-09, Vol.23 (9), p.1042-1050 [Peer Reviewed Journal]2023 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license ;Copyright © 2023 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license. Published by Elsevier Ltd.. All rights reserved. ;2023. The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license. This work is published under https://creativecommons.org/licenses/by/3.0/ (theLicense”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 1473-3099 ;EISSN: 1474-4457 ;DOI: 10.1016/S1473-3099(23)00270-0 ;PMID: 37336224Full text available |
| 10 |
Material Type: Article
|
|
Trends in invasive Haemophilus influenzae serotype a disease in England from 2008–09 to 2021–22: a prospective national surveillance studyThe Lancet infectious diseases, 2023-10, Vol.23 (10), p.1197-1206 [Peer Reviewed Journal]2023 ;Crown Copyright © 2023 Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license. ;Copyright Elsevier Limited Oct 2023 ;ISSN: 1473-3099 ;EISSN: 1474-4457 ;DOI: 10.1016/S1473-3099(23)00188-3 ;PMID: 37356443Full text available |
| 11 |
Material Type: Article
|
|
No evidence for Haemophilus influenzae serotype replacement in Europe after introduction of the Hib conjugate vaccineThe Lancet infectious diseases, 2008-05, Vol.8 (5), p.275-276 [Peer Reviewed Journal]Elsevier Ltd ;Copyright Elsevier Limited May 2008 ;ISSN: 1473-3099 ;EISSN: 1474-4457 ;DOI: 10.1016/S1473-3099(08)70078-1 ;PMID: 18471770 ;CODEN: LANCAOFull text available |
| 12 |
Material Type: Article
|
|
No evidence for capsule replacement following mass immunisation with meningococcal serogroup C conjugate vaccines in England and WalesThe Lancet infectious diseases, 2006-10, Vol.6 (10), p.616-617 [Peer Reviewed Journal]2006 Elsevier Ltd ;ISSN: 1473-3099 ;EISSN: 1474-4457 ;DOI: 10.1016/S1473-3099(06)70584-9 ;PMID: 17008169Full text available |
| 13 |
Material Type: Article
|
|
COVID-19 vaccine effectiveness against the omicron (BA.2) variant in EnglandThe Lancet infectious diseases, 2022-07, Vol.22 (7), p.931-933 [Peer Reviewed Journal]2022 Elsevier Ltd ;2022. Elsevier Ltd ;2022 Elsevier Ltd. All rights reserved. 2022 Elsevier Ltd ;ISSN: 1473-3099 ;EISSN: 1474-4457 ;DOI: 10.1016/S1473-3099(22)00309-7 ;PMID: 35623379Full text available |
| 14 |
Material Type: Article
|
|
Risk factors for SARS-CoV-2 among patients in the Oxford Royal College of General Practitioners Research and Surveillance Centre primary care network: a cross-sectional studyThe Lancet Infectious Diseases, 2020-09, Vol.20 (9), p.1034-1042 [Peer Reviewed Journal]2020 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license ;Copyright © 2020 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license. Published by Elsevier Ltd.. All rights reserved. ;2020. Not withstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at http://creativecommons.org/licenses/by/4.0 ;2020. The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license. This work is published under https://creativecommons.org/licenses/by/3.0/ (theLicense”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2020 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license 2020 ;ISSN: 1473-3099 ;EISSN: 1474-4457 ;DOI: 10.1016/S1473-3099(20)30371-6 ;PMID: 32422204Digital Resources/Online E-Resources |
| 15 |
Material Type: Article
|
|
Duration of protection of ancestral-strain monovalent vaccines and effectiveness of bivalent BA.1 boosters against COVID-19 hospitalisation in England: a test-negative case-control studyThe Lancet infectious diseases, 2023-11, Vol.23 (11), p.1235-1243 [Peer Reviewed Journal]2023 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY-NC-ND 4.0 license ;Copyright © 2023 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY-NC-ND 4.0 license. Published by Elsevier Ltd.. All rights reserved. ;2023. The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY-NC-ND 4.0 license. This work is published under http://creativecommons.org/licenses/by-nc-nd/3.0/ (theLicense”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 1473-3099 ;EISSN: 1474-4457 ;DOI: 10.1016/S1473-3099(23)00365-1 ;PMID: 37453440Full text available |
| 16 |
Material Type: Article
|
|
Effectiveness of one dose of MVA–BN smallpox vaccine against mpox in England using the case-coverage method: an observational studyThe Lancet infectious diseases, 2023-07, Vol.23 (7), p.828-835 [Peer Reviewed Journal]2023 ;Crown Copyright © 2023 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license. ;Copyright Elsevier Limited Jul 2023 ;ISSN: 1473-3099 ;EISSN: 1474-4457 ;DOI: 10.1016/S1473-3099(23)00057-9 ;PMID: 36924787Full text available |
| 17 |
Material Type: Article
|
|
Resurgence of scarlet fever in England, 2014–16: a population-based surveillance studyThe Lancet infectious diseases, 2018-02, Vol.18 (2), p.180-187 [Peer Reviewed Journal]2018 Elsevier Ltd ;Copyright © 2018 Elsevier Ltd. All rights reserved. ;Copyright Elsevier Limited Feb 1, 2018 ;2018. Elsevier Ltd ;ISSN: 1473-3099 ;EISSN: 1474-4457 ;DOI: 10.1016/S1473-3099(17)30693-X ;PMID: 29191628Full text available |
| 18 |
Material Type: Article
|
|
Transmission dynamics and effect of control measures on the 2022 outbreak of mpox among gay, bisexual, and other men who have sex with men in England: a mathematical modelling studyThe Lancet infectious diseases, 2024-01, Vol.24 (1), p.65-74 [Peer Reviewed Journal]Copyright © 2024 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license. Published by Elsevier Ltd.. All rights reserved. ;2024. The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license. This work is published under https://creativecommons.org/licenses/by/3.0/ (theLicense”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 1473-3099 ;EISSN: 1474-4457 ;DOI: 10.1016/S1473-3099(23)00451-6 ;PMID: 37708908Full text available |
| 19 |
Material Type: Article
|
|
Safety, immunogenicity, and reactogenicity of BNT162b2 and mRNA-1273 COVID-19 vaccines given as fourth-dose boosters following two doses of ChAdOx1 nCoV-19 or BNT162b2 and a third dose of BNT162b2 (COV-BOOST): a multicentre, blinded, phase 2, randomised trialThe Lancet Infectious diseases, 2022-08, Vol.22 (8), p.1131-1141 [Peer Reviewed Journal]cc_by_4 ;ISSN: 1473-3099 ;EISSN: 1474-4457 ;DOI: 10.1016/s1473-3099(22)00271-7Full text available |
| 20 |
Material Type: Article
|
|
Universal hepatitis B vaccinationThe Lancet infectious diseases, 2008-02, Vol.8 (2), p.87-88 [Peer Reviewed Journal]Elsevier Ltd ;2008 Elsevier Ltd ;Copyright Elsevier Limited Feb 2008 ;ISSN: 1473-3099 ;EISSN: 1474-4457 ;DOI: 10.1016/S1473-3099(08)70004-5 ;PMID: 18222157 ;CODEN: LANCAOFull text available |
Results 1 - 20 of 21 for All Library Resources
Sorted by:
Sorted by:
RelevanceOr hit Enter to replace sort method
- Relevance
- Date-newest
- Date-oldest
- Popularity
- Author
- Title
Personalize your results
Refine Search Results
Expand My Results
Refine My Results
Creation Date
- Before 2008 (3)
- 2008 To 2016 (4)
- 2017 To 2019 (3)
- 2020 To 2022 (6)
- After 2022 (6)
-
More options
Subject
- Infectious Diseases (19)
- Life Sciences & Biomedicine (17)
- Science & Technology (17)
- Humans (17)
- Vaccines (11)
- Public Health (11)
- Epidemiology (8)
- Adolescent (8)
- Immunization (8)
- England - Epidemiology (8)
- Trends (7)
- Child (7)
- Child, Preschool (7)
- Male (7)
- Infant (7)
- Female (6)
- Infections (6)
- Antibodies (5)
- Adult (5)
- Coronaviruses (5)
-
More options
Databases
- ProQuest Central (21)
- MEDLINE (17)
- Coronavirus Research Database (2)
- LSHTM Research Library (1)
-
More options
|
||||
 |
INSPIRE LIBRARY - TON DUC THANG UNIVERSITY |  |
(84-028) 37 755 057 | Feedback |
| 19 Nguyen Huu Tho St. Dist.7, HCM |  |
thuvien@tdtu.edu.vn | ||